Usefulness of preoperative peripheral blood GPC3‐positive circulating tumor cells in subclassification of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma: a retrospective cohort study
Glypican-3-positive CTCs are effective for subclassifying BCLC stage B HCC. When combined with the up-to-7 criteria, they may help with the development of new treatment strategies.
Authors
- Naruhiko Honmyo (ORCID: https://orcid.org/0000-0002-6201-6812)
- Hideki Ohdan (ORCID: https://orcid.org/0000-0002-9066-1288)
- Takeshi Tadokoro (ORCID: https://orcid.org/0000-0001-6617-9750)
- Masahiro Ohira (ORCID: https://orcid.org/0000-0002-5433-5303)
- Tsuyoshi Kobayashi (ORCID: https://orcid.org/0000-0001-7364-1798)
- Yosuke Namba (ORCID: https://orcid.org/0000-0003-0578-9517)
- Sotaro Fukuhara (ORCID: https://orcid.org/0000-0003-2638-3807)
- Hiroyuki Tahara (ORCID: https://orcid.org/0000-0002-4925-6037)
- Ko Oshita (ORCID: https://orcid.org/0000-0002-3384-3800)
- Yoshito Hirata
- Seiichi Shimizu (ORCID: https://orcid.org/0000-0002-6985-945X)
- Ryosuke Nakano
- Shintaro Kuroda (ORCID: https://orcid.org/0000-0001-9881-0420)
- Hiroshi Sakai (ORCID: https://orcid.org/0000-0002-7092-8440)
- Yuka Tanaka
- Kentaro Ide
Institutions
- Hiroshima University (JP)
Publication Details
- Journal
- Hepatology Research
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1111/hepr.14211
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development